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Available online 28 July 2016Deep sequencing techniques and advanced data analysis methods recently enabled the characterization of thou-
sands of circular RNA isoforms (circRNAs) from a number of tissues and organisms. There is emerging evidence
that some circRNAs may have important biological functions or serve as diagnostic biomarkers in disease
conditions.
In order to analyze circRNA expression in the heart and its changes in different conditions we performed RNA-Seq
analysis of ribosome-depleted libraries from rats (neonatal and adult), mice (sham or after transverse aortic con-
striction, TAC) and humans (failing, non-failing). All samples were sequenced after treatment with exonuclease
RNase R or a mock treatment and N9000 candidate circRNAs were detected for each species.
Additionally, we performed separate isolation of nuclear and cytoplasmic RNA and co-immunoprecipitated RNA
interacting with endogenous argonaute 2 (Ago2) in primary cardiac myocytes. We found circRNAs to be signif-
icantly enriched in the cytoplasm compared to linear transcripts and to have a similar level of association with
Ago2.
Notably in all three species we observed dozens of circRNAs arising from the titin (Ttn) gene, which is known to
undergo highly complex alternative splicing during heart maturation. Correspondingly we observed extensive
differential regulation of Ttn circRNAs between neonatal and adult rat hearts, suggesting that circRNA formation
could be involved in the regulation of titin splicing.
We expect that our inventory of cardiac circRNAs, as well as the information on their conservation and differential
expressionwill provide an important basis for further studies addressing their function and suitability as biomarkers.






Although circular RNA molecules (circRNAs) have been ﬁrst de-
scribed a long time ago, it was not until recently, that it was discovered
how widespread their expression is [1–3]. CircRNAs typically arise
through splicing of a splice donor to an upstream localized splice accep-
tor, thus forming a closed circle consisting of regular 3′-5′ carbon link-
ages throughout. Molecules formed this way most often arise at
known exons and annotated splice sites and are also termed “exonic”
circRNAs to distinguish them from “intronic” forms that may arise
from introns and contain a 2′-5′ carbon linkage at the branch point
(similar to lariat RNA) [3].
It is currently assumed that due to their circular structure and the
absence of a 5′ cap, circRNAs are not translated into proteins (thoughe und Toxikologie, Technische
rdt).
. This is an open access article undertheremight be exceptions [4]). It has been reported for several circRNAs
that they can exert cellular functions by binding to and inhibiting
microRNAs [2,5], but this mechanism could be reserved for circRNAs
with exceptionally high number of target sites for a speciﬁc microRNA.
It appears plausible that they could assume further functions, similar
to long non-coding RNAs (lncRNAs).
CircRNAs have signiﬁcantly longer half-lives than linear RNA mole-
cules, possibly due to reduced exonuclease susceptibility [2] and in-
creasing evidence suggests that they can be secreted and identiﬁed in
plasma,whichmakes thempromising candidate disease biomarkers [6].
A typical feature of circRNAs is the “backsplice” or “head-to-tail” splice
junction, where exons in the RNA appear in reversed order compared to
their chromosomal localization (Fig. 1A, bottom). Deep sequencing
reads spanning this junction allow recognition of circRNA candidates.
These can be further conﬁrmed through enrichment after treatment
with the exonuclease RNase R, which digests linear but not circular RNA.
A characterization of cardiac circRNAs has previously been per-
formed in the hearts of healthy adult mice, resulting in the discoverythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Identiﬁcation and characterization of cardiac circRNAs. (A) Processing of heart samples from rats (neonatal, NRH, and adult, ARH, n=3 each),mouse (pressure overload induced by
transverse aortic constriction, TAC, n = 2 and sham, n = 3) and humans (failing, HF, non-failing, HN, n = 2 each) for circRNA identiﬁcation. Deep sequencing reads (shown in gray)
spanning the backsplice allow identiﬁcation of circRNA candidates in RNA-Seq data. (B) Venn diagram of identiﬁed backsplices and their conservation. (C) Density histogram of
relative enrichment of backsplice-spanning reads from highly expressed rat circRNA candidates (detected with ≥3 reads in either all NRH or all ARH mock treated samples, n = 988)
and regular splice junction spanning reads after RNase R digestion. Dashed line indicates the selected threshold of 21.1 (n = 767 at ≥21.1). (D) Relative enrichment of reads from the
known nuclear lncRNAs Malat1 and Meg3 and cytoplasm-enriched Gapdh in the respective compartments to assess successful separation of the two fractions. (E) Relative distribution
of circRNAs and linear transcripts between the cytoplasmic and nuclear compartments of NRCMs. (F) Enrichment of the known microRNA targets H19 and Pten (compared to Gapdh)
in the Ago2-RIP to assess successful enrichment of microRNA targets. Hsp90-RIP served as control. (G) Comparison of the enrichment of circular and linear transcripts in the Ago2-RIP
in NRCMs. (All p-values were calculated using a Mann–Whitney U test).
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and rats and changes in disease conditions have so far not been
reported.
Here we characterize circRNAs in the hearts of humans, mice and
rats in native and disease conditions and assess further characteristics
of this class of molecules, such as their cellular localization and associa-
tion with microRNAs.
2. Materials and methods
Materials andmethods are described in the online data supplement.
3. Results and discussion
3.1. Description of analyzed samples
We performed deep sequencing analysis of ribosomal-RNA(rRNA)-
depleted heart samples from rat (neonatal, NRH, and adult, ARH),
mouse (sham and 3weeks after pressure overload using transverse aor-
tic constriction, TAC) and human (non-failing hearts, HN, heart-failure
patients, HF). Each sample was treated with RNase R or mock treated
to assess enrichment of exonuclease-resistant circRNAs (Fig. 1A).Additionally, we performed separate isolation of cytoplasmic and
nuclear RNA (2 samples each) and ribonucleoprotein immunoprecipita-
tion (RIP) with antibodies against endogenous argonaute 2 (Ago2) and
heat shock protein 90 (Hsp90) as control (2 samples each) in neonatal
rat cardiac myocytes (NRCMs). Overall 38 RNA-Seq libraries were gen-
erated and sequenced on an Illumina HiSeq 2500 machine. Suppl.
Table 1 shows an overview of all samples and obtained reads that
passed quality control. To conﬁrm the presence of cardiac failure, levels
of atrial natriuretic peptide (NPPA) and β-myosin heavy chain (MYH7)
mRNA were measured using qPCR in the human samples and showed
strong elevation in failing hearts (Suppl. Table 2A). Mice were assessed
using the ventricle weight normalized to bodyweight ratio, Nppa (both
strongly elevated) and ejection fraction (strongly reduced, Suppl. Table
2B).
We applied the algorithm established byMemczak et al. [2] to quan-
tify backsplices and linear junctions. Only candidates supported by at
least three unique readswere reported for each sample.We determined
N9000 candidate circRNAs for each species, of which ≈30% were
conserved between mouse and rat and ≈10% were conserved in all
three species (Fig. 1B). To our knowledge this is the ﬁrst extensive anal-
ysis of circRNA conservation in the myocardium between several
species.
Fig. 2. Conﬁrmation of select circRNA candidates and differential expression analysis. (A) Relative enrichment of some of the top expressed circRNAs in adult mouse heart after digestion
with RNase R (normalized to linear transcripts), quantiﬁed with qPCR (n ≥ 3). Values N1 indicate increased stability compared to linear transcripts of the respective genes. (B) Sum of all
reads falling on backsplices of high-conﬁdence circRNAs in mock-treated samples. High-conﬁdence circRNAs were deﬁned as those showing an average enrichment ≥21.1 in RNase R
treated samples. *p b 0.05 in a two-way ANOVA analysis with Bonferroni's correction for multiple testing. (C) Overview of the differential expression of circRNAs from Suppl. Table 6A
in adult and neonatal rat hearts (n = 767). CircRNAs from select loci (indicated below) are highlighted in respective colors. Dashed lines indicate the interval of ±2× fold change. (D)
As in C for circRNAs in human samples (Suppl. Table 6C, n = 1363). (E) As in C for circRNAs in mouse samples (Suppl. Table 6B, n = 675). (F) Conﬁrmation of differential expression
of selected circRNAs in neonatal and adult rat hearts (n = 6 each) and sham and TAC treated mouse hearts (n = 4–5 each) using qPCR. *p b 0.05 in a t-test for independent samples.
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nomic location and full results are reported in Suppl. Table 3 (rat),
Suppl. Table 4 (mouse) and Suppl. Table 5 (human).
3.2. CircRNAs are highly enriched in the cytoplasm of NRCMs
To ﬁnd a cutoff for expected enrichment of circRNAs after RNase R di-
gestion with our protocol, we compared the enrichment of robustly
expressed rat circRNA candidates (≥3 backsplice-spanning reads detected
in either all mock NRH or all mock ARH samples, n= 988) to linear junc-
tions (Fig. 1C). Most circRNA candidates localized to a population distinct
from linear junctions with few (likely false positives) showing low or no
enrichment. Based on the distributions of the twopopulationswedeﬁned
a threshold for relative enrichment (21.1≈ 2.14) with an expected false-
positive rate b 5%, to select high-probability and high expression rat
circRNAs that were retained for further analyses.
To assess cytoplasmic vs. nuclear localization we ﬁrst conﬁrmed suc-
cessful separate isolation of the two fractions by quantifying in our librar-
ies the reads falling on representative RNAs with known localization. We
found (as previously reported [8]) that the long non-coding RNAsMalat1
and RGD1566401(Meg3) were highly enriched in the nuclear fraction
and the mRNA of Gapdh in the cytoplasmic fraction (Fig. 1D).
Although it has been previously described that circRNAs can localize
to the cytoplasm [1,2], we were surprised to ﬁnd that they were highly
enriched there compared to linear transcripts (Fig. 1E). To our knowl-
edge this is theﬁrst deep sequencing analysis comparing the subcellular
localization of circRNAs to linear RNAs and it remains currently un-
known how circular RNAs exit the nucleus. It appears unlikely that a se-
lective export mechanism exists for circRNAs that is more efﬁcient than
the regular mRNA export. A possible explanation could be selective de-
pletion of circRNAs in the nucleus (e.g. through degradation), which is
absent or much weaker in the cytoplasm.
3.3. CircRNAs show a similar extent of interaction with the RNA-induced si-
lencing complex (RISC) as do linear transcripts in NRCMs
We indirectly assessed the overall extent of circRNA-microRNA in-
teractions on transcriptome level using (endogenous) Ago2-RIP-se-
quencing in NRCMs, with an Anti-Hsp90 antibody serving as control.
To conﬁrm successful immunoprecipitation and microRNA target en-
richment, we quantiﬁed sequencing reads falling on known targets,
the lncRNA H19 and Pten, and found strong enrichment in the Ago2-
RIP but not in the Hsp90-RIP, while Gapdh was depleted (Fig. 1F).
A comparison of circRNAs to linear transcripts in the Ago2-RIP (nor-
malized to baseline expression in NRH) showed a similar relative en-
richment of the two RNA forms (Fig. 1G), suggesting that circRNAs, on
average, interact with microRNAs to a similar extent as do linear tran-
script. Interestingly the most abundant circRNA detected in the Ago2-
RIP stemmed from the Slc8a1 gene,which codes for the sodium-calcium
exchanger (NCX1). Itwas also among themost abundant circRNAs in all
three species and is one of the very few mammalian circRNAs that has
been discovered before the advent of deep sequencing technology [4].
3.4. Conﬁrmation of select circRNA candidates
To further conﬁrm the circularity of select candidates we quantiﬁed
their enrichment in RNase R treated vs. mock treated samples using
qPCR (Fig. 2A). We observed that circRNAs with higher predicted
lengths showed lower enrichment, possibly due to minimal endonucle-
ase contamination or small degree of RNA degradation during or after
RNA isolation (m004295: 1.8 kb, m005505: 6.2 kb, m005504: 6,5 kb
vs. m001237: 0.4 kb, m003757: 0.6 kb). In addition, we quantiﬁed rela-
tive efﬁciency of reverse transcription (RT) with random hexamer vs.
oligo(dT) primers. Circular RNAs do not have poly-A tails and therefore
an RT with random hexamers is expected to show an apparent enrich-
ment of the circular form compared to oligo(dT), when normalized tothe linear mRNA (further described in supplementary methods). As ex-
pected the selected circRNAs showed marked enrichment in this assay
(Suppl. Fig. 1, Ttn circRNAs not included due to very long distance of
circRNA exons from the poly-A tail).
3.5. Differential expression analysis of cardiac circRNAs
To calculate overall circRNA expression levels, normalized backsplice-
spanning read counts of all candidates meeting the RNase R enrichment
threshold (n N 9000 in each species) were summed up.We observed sig-
niﬁcantly lower overall circRNA expression in adult compared to neonatal
rat hearts (Fig. 2B). Interestingly human hearts showed a baseline level
comparably high to NRH, about double of that in adult rats and mice.
We then selected robustly expressed circRNA candidates for each
species (detected with ≥3 backsplice-spanning reads in each mock-
treated sample of at least one treatment group, e.g. in all NRH_mock
or all ARH_mock samples, and passing the RNase R threshold) and per-
formed a statistical analysis for differential expression in the analyzed
conditions (Suppl. Tables 6A, B and C for rat, mouse and human respec-
tively). Replicates from individual groups clustered well together in a
hierarchical clustering analysis (Suppl. Fig. 2).
As expected from the summary analysis (Fig. 2B) we found a large
number of strongly and signiﬁcantly (with a false discovery rate,
FDR b 0.1) regulated circRNAs between neonatal and adult rat hearts
(Suppl. Table 6A and Fig. 2C).
We detected over 40 backsplices stemming from the sense strand of
the titin (Ttn) gene in all three species, most of which were enriched in
RNase R treated samples. Titin transcripts undergo highly complex, de-
velopmentally controlled differential splicing, resulting in many thou-
sands of possible isoforms [9]. Correspondingly we found several titin-
derived circRNAs which were speciﬁcally and strongly enriched in
adult and others in neonatal rat hearts (Fig. 2C; Suppl. Table 6A). We
further conﬁrmed this ﬁnding by qPCR in independent samples (Fig.
2F). Also one titin-derived circRNA was signiﬁcantly downregulated in
mice subjected to pressure overload (Fig. 2F; Suppl. Table 6B).
It has been reported that the formation of circRNAs can inﬂuence
mRNA processing by competing with linear splice events [10]. It appears
therefore possible that circRNA formation could be one of the driving
forces behind the diversity of titin splicing. Furthermore missplicing of
titin has been causally linked to hereditary cardiomyopathy in rats and
humans [11]. It is therefore tempting to speculate that perturbation of
circRNA levels could be contributing to the disease phenotype in rodents
and patients.
We also found 2 other genes (Eya3 and Scmh1) that, similarly to
titin, produced differentially regulated circRNAs, of which some were
enriched by at least 2-fold in neonatal and others in adult rat hearts
with an FDR b 0.1 (Fig. 2C and F; Suppl. Table 6A). These examples pro-
vide strong evidence for speciﬁc regulation of circRNA formation, inde-
pendent of transcriptional regulation.
Under disease conditions a reexpression of fetal genes such as NPPA
and MYH7 typically takes place in cardiomyocytes. Both in mouse and
human failing hearts we observed a tendency towards increased circRNA
expression (Fig. 2B and visible as a shift in the point clouds in Fig. 2D and
E) compared to non-failing hearts. However less circRNAs were differen-
tially expressed and the extent of regulation was less pronounced com-
pared to neonatal vs. adult rat hearts (Suppl. Tables 6B and C).
Apart from titin, several other genes showed ahighnumber of differ-
ent circRNA isoforms, notably ryanodine receptor 2 (RYR2), which
expressed over 100 circRNA isoforms in human hearts (Suppl. Table 7).
4. Conclusions
Taken together our data provide an extensive catalogue of circRNAs
in human, mouse and rat hearts and their conservation between the
three species.
107S. Werfel et al. / Journal of Molecular and Cellular Cardiology 98 (2016) 103–107CircRNAs appear to be robustly expressed and show differential reg-
ulation in postnatal development and cardiac disease.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.yjmcc.2016.07.007.
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Glossary
Backsplice (or head-to-tail splice junction): a splice junction that produces circular RNA and
can be identiﬁed in RNA-Seq data due to an exchanged order of exons
RNA-Seq: deep sequencing of RNA samples.
